MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Maestrodatabase.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Maestrodatabase.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Maestrodatabase.com most likely does not offer any adult content.
Popular pages
-
MAESTrO: About MAESTrO
About Emily Emily has been with MAESTrO Database since graduating from a Bachelor of Pharmacy in 2018. She takes an active role in the management of international regulatory and reimbursement versions...
-
MAESTrO: Blog
Contact us Newsletter Sign up to receive our newsletter MAESTrO Daily for market access updates and insights. Free for two weeks. No consultants please. Subscribe
-
MAESTrO: Schedule of Pharmaceutical Benefits - 1 October 2024
Schedule of Pharmaceutical Benefits - 1 October 2024 1 October 2024 - The October 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. The October issue of the Schedule incl...
-
MAESTrO: Public Summary Documents (first time decisions not to recommend and deferrals) - May 2024
Public Summary Documents (first time decisions not to recommend and deferrals) - May 2024 PBAC meeting 1 October 2024 - The Public Summary Documents (first time decisions not to recommend and deferral...
- MAESTrO: Blog
-
MAESTrO: Dupixent (dupilumab) approved in the US as the first ever biologic medicine for patients
Dupixent (dupilumab) approved in the US as the first ever biologic medicine for patients with COPD 27 September 2024 - Following recent approvals in the EU and China, the US approval is based on two l...